Belgian CRO launches EU joint venture with Chromatography Institute

By Dani Bancroft contact

- Last updated on GMT

Belgian CRO launches EU joint venture with Chromatography Institute

Related tags: High performance liquid chromatography

The Research Institute for Chromatography (RIC) and Anacura have joined forces to create anaRIC biologics, an R&D and GMP analytical specialist CRO for biologics.

The RIC combined forces with Anacura on the basis that specialist analysis of biologics requires a different expertise and dedicated workspace to that of small molecules.

As a privately owned venture, anaRIC biologics will focus on the analysis of biologics such as antibodies, proteins and peptides for the therapeutic, diagnostic and vaccine markets.

Katleen Broos, spokesperson at anaRIC biologics, told us that this new collaboration would offer existing customers of both the contract research organisations Anacura and the RIC access to each firm’s sites for specialist services on biologics and biosimilars.

“There is a nice interplay between the two facilities and everything is in place for the smooth transfer from the R&D to the GMP space. For customers, we're an independent service provider for products at the early stage up until market approval,” ​she explained.

Broos added anaRIC offers a "complete" analytical package, from discovery through to market approval.

anaric_biologics_cro_belgium_ric_anacura_analytical_pharma_lab

Yves Meyvis, another spokesperson for anaRIC biologics, told us: “After talking to our existing customers, we felt the need for an independent quality control lab - we want to be a single point of contact for analytics. Our core focus is offering solutions in an R&D and GMP setting.”

GMP site

anaRIC biologics itself is based in a purpose-build facility outside Ghent in Evergem, around 60km from the RIC in Kortrijk, where Anacu

ra has been located since September 2014.

Between the two sites the collaboration has access to 250 employees, 80 of which are part of the pure analytics team, for characterization and GMP.

Broos also explained the 10,000 sq meter facility uses automated environmental controls of its labs, which reduces risk of residue transfer between LC and GC instruments.

“Our instruments include Agilent and Waters HPLC, UPLC and mass spectrometry equipment. Other technologies, such as those for Pharmacopoeia testing and electrophoresis, have been acquired based on robustness, automation and low volume features,”​ she added.

Broos told us there is a lot of exchange happening in the mass spectrometry space as well, which is where anaRIC biologics is looking to expand.

However: “Although we're also looking to expand our US client base, we're not looking to build over there. We're here to help US customers launch their products in the European market.”​ 

anacura_cro_anaRIC_biologics_gmp_chromatography_evergem
Anacura's site in Evergem, Belgium
(Images: anaRIC biologics)

Related news

Related products

show more

Using SDTM, ADaM, and SEND

Using SDTM, ADaM, and SEND

Formedix | 09-Nov-2022 | Technical / White Paper

This article gives an overview of SDTM, ADaM, SEND and ARM, and discusses how these CDISC standards fit in with the wider clinical trial process, and how...

How to design an effective CRF

How to design an effective CRF

Formedix | 10-Oct-2022 | Technical / White Paper

CRFs and eCRFs are used for gathering patient data during clinical trials. They play a crucial role in helping to assess the safety and efficacy of clinical...

The Complexities of Ophthalmic Drug Development

The Complexities of Ophthalmic Drug Development

Altasciences | 04-Oct-2022 | Technical / White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

Because When It's On the Line... Capability Matters.

Because When It's On the Line... Capability Matters.

Baxter BioPharma Solutions | 01-Oct-2022 | Product Brochure

Baxter’s BioPharma Solutions business supports leading pharmaceutical companies in meeting their commercialization objectives by providing scientific expertise,...

Related suppliers

Follow us

Products

View more

Webinars